Ferroptosis suppressor protein 1-mediated ferroptosis suppression in sepsis: non-canonical antioxidant pathways, inflammatory regulation, and therapeutic perspectives

Read full text
Authors: 田永桓, Zaiyong Li, Tian Tian, Hudie Zhu, Manhong Zhou, Xianping Long, Song Wang
Cited by: 1
References: 135

Abstract

Sepsis, defined as life-threatening organ dysfunction caused by a dysregulated host response to infection, remains a global health challenge characterized by high mortality and limited therapeutic options. Recent evidence identifies ferroptosis—an iron-dependent form of regulated cell death driven by the lethal accumulation of lipid peroxides—as a pivotal mechanism underlying sepsis-induced organ damage. Ferroptosis Suppressor Protein 1 (FSP1) has emerged as a critical endogenous inhibitor of ferroptosis that operates independently of the canonical GPX4/glutathione system. This review provides a comprehensive overview of recent research on FSP1 in the context of sepsis-associated organ injury. We detail the multifaceted molecular mechanisms through which FSP1 inhibits ferroptosis, including the canonical FSP1-CoQ 10 -NAD(P)H axis, the non-canonical vitamin K cycle, ESCRT-III-mediated membrane repair, and the newly characterized vitamin B2-dependent metabolic stability pathway. Furthermore, we highlight the newly discovered STING-FSP1 signaling axis, where cGAS-STING activation transcriptionally represses FSP1, thereby driving endothelial ferroptosis and vascular leakage during sepsis. Additionally, potentially conserved pathways extrapolated from other acute injury models (e.g., ALKBH5, CD36, and SENP3) are discussed to propose novel research directions. The organ-specific roles and protective mechanisms of FSP1 in sepsis-induced injuries of the lungs, heart, liver, kidneys, and brain are systematically summarized. Finally, we evaluate the prospects and challenges of targeting FSP1-related pathways, such as Nrf2 activation and STING inhibition, as potential therapeutic strategies for sepsis. Overall, This review aims to provide new insights into the “inflammation-cell death” cascade in sepsis and offer a theoretical foundation for developing FSP1-targeted interventions to suppress ferroptosis.

Fields of Study & Subjects

Ferroptosis and cancer prognosis Inflammasome and immune disorders interferon and immune responses

Publication details

Journal / source
Frontiers in Immunology
Publisher
Frontiers Media SA
Volume
17
Pages
1892904–1892904
Publication date
7 August 2026
Language
EN